fixOflex was selected out of more than 45 emerging company applications to present a talk during the cataract extraction session. The goal of Prof. Pallikaris talk will be to introduce ΕYE PCR and our product to the audience, comprising hundreds of leaders from the ophthalmic clinical, business, and financial communities.
Prof. Pallikaris along with EYE PCR team joined the 36th International Congress
From January 27th to 29th 2022, the 27th Pallas Kliniken Ophthalmological Conference (OTO) took place with numerous highlights. The OTO is a three-day ophthalmologists’ congress that is now well-known throughout Switzerland. LASIK pioneer Ioannis Pallikaris talked about his new invention of the fixOflexTM implant. Click the link for more details: https://www.pallas-kliniken.ch/de/news/artikel/oto-2022-jetzt-anmelden
Professor Pallikaris joined the ESCRS Congress in Amsterdam presenting our product fixOflex and reporting our clinical experience with 108 patients from our clinical study in Alexandria of Egypt. You can visit ESCRS on Demand to watch recorded session from the Congress by clicking here.
EYE-PCR is participating with a presentation of fixOflex using the early outcome of a cohort of 108 patients from the on going Clinical Trial in Alexandria, Egypt. The presentation can be accessed by clicking here.
EYE-PCR has presented a poster referring to the on going Clinical Trial in Alexandria. The early outcome of a cohort of 72 patients was promising. A video of Prof. Ioannis Pallikaris presenting the fixOflex Ring was released.
EYE PCR is happy to announce that the abstract submitted by Prof Ahmed El Massry has been accepted